We monitored the progress of our simulation index (let’s call it ‘the Pollen Top 50’) against two benchmarks:

The CCi30, an index comprising the 30 largest cryptocurrencies weighted by market cap.

• A 50:50 mix of Bitcoin, the world’s most recognisable cryptocurrency, and
• AVAX, the native token of our host blockchain Avalanche.

The chart below shows that if you’d invested USDT 100,000 in the Pollen Top 50 on May 16, shortly after we launched the Pollen Virtual beta (in the midst of a severe downturn), by the end of May your investment would have been worth around USDT 80,000 with net transaction costs included (the gross figure is over 100,000).

However, if you’d invested the same figure in the CCi30, you’d have ended up with less than USDT 60,000. If you’d invested in BTC-AVAX, you’d have finished with little more than USDT 50,000.